Direct to Implant Breast Reconstruction Based Pre- or Retropectoral
Direct to Implant Extracellular Matrix Hammock Based pre-or Retropectoral Breast Reconstruction
1 other identifier
interventional
70
2 countries
3
Brief Summary
The purpose of this study is to examine different outcomes of breast reconstruction in women who are treated for breast cancer with skin sparing mastectomy and subsequently a primary implant based reconstruction by one of two different techniques with either a pre- or retropectoral placement of the implant. The main objective of the study is to establish whether one of these techniques may result in a superior outcome and thus should be recommended as first choice treatment rather than the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2017
CompletedStudy Start
First participant enrolled
May 1, 2017
CompletedFirst Posted
Study publicly available on registry
May 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedAugust 29, 2019
August 1, 2019
2.9 years
May 1, 2017
August 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Breast animation deformity
Breast animation deformity (BAD) is one of the more unpleasant cosmetic results that can be seen after breast reconstruction with a retropectoral placed implant. The degree of breast distortion will be evaluated by two experienced plastic surgeons and classified according to the published classification by Spear S. Because the degree of breast distortion will be the primary outcome measure of this randomised trial, the sample size will be based on assumptions regarding the grade of distortion between groups. For this purpose, the distortion will be divided into two groups: 1) Severe distortion containing degree 3 and 4 and 2) Moderate distortion containing degree 1 and 2. In bilateral cases the most severe side will be the one used for comparison
12 months
Secondary Outcomes (1)
Shoulder function
3 and 12 months
Other Outcomes (8)
Quality of Life
12 months
Postoperative pain
3 months
Postoperative complications
3 months
- +5 more other outcomes
Study Arms (2)
Retropectoral immediate breast reconstruction
ACTIVE COMPARATORParticipants are randomized to immediate breast reconstruction with the implant placed retropectoral.
Prepectoral immediate breast reconstruction
ACTIVE COMPARATORParticipants are randomized to direct to immediate breast reconstruction with the implant placed prepectoral using acellular dermal matrix for support.
Interventions
Immediate reconstruction with the implant placed in a standard fashion, i.e. retropectoral in combination with an acellular dermal matrix.
Immediate breast reconstruction with the implant placed prepectoral supported by acellular dermal matrix alone.
Eligibility Criteria
You may qualify if:
- Women over 18 years referred to the Department of plastic surgery, Odense University Hospital, Lillebaelt Hospital Vejle, Denmark or Telemark Hospital, Skien, Norway between January 2017 and July 2018, who are found eligible for immediate breast reconstruction.
You may not qualify if:
- Dementia that makes it impossible to obtain informed consent
- Non-Danish speaking patients from whom informed consent cannot be obtained by interpreter
- Tobacco users
- Women with known hypertension treated with more than one drug
- Women who had pre-surgical radiation therapy.
- Women planned to have postsurgical radiation therapy.
- BMI above 32 or below 22
- However, the final decision relies on sufficient thickness of the skin flaps after mastectomy prior to immediate reconstruction.
- Invited patient will receive both oral and written participant information after which there will be as many days for reflection as the treatment guaranty for cancer allows.
- Patients considering participation will be invited for a second consultation where written informed consent will be obtained from all who accept the invitation. Randomization will be performed during surgery, prior to reconstruction. Patients who do not wish to participate will be reconstruction with the implant placed retropectoral.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- Sygehus Lillebaeltcollaborator
- Sykehuset Telemarkcollaborator
Study Sites (3)
Odense University Hospital
Odense, 5000, Denmark
Lillebaelt Hospital Vejle
Vejle, 7100, Denmark
Telemark Hospital
Skien, 3710, Norway
Related Publications (1)
Dyrberg DL, Gunnarsson GL, Bille C, Sorensen JA, Thomsen JB. Direct-to-Implant Extracellular Matrix Hammock-based Breast Reconstruction; Prepectoral or Subpectoral? Trials. 2020 Feb 10;21(1):160. doi: 10.1186/s13063-020-4125-6.
PMID: 32041661DERIVED
Study Officials
- STUDY CHAIR
Jørn Bo JB Thomsen, MD, PhD
Center Hospital Vejle, Institute of Regional Health Research, University of Southern Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
May 1, 2017
First Posted
May 8, 2017
Study Start
May 1, 2017
Primary Completion
April 1, 2020
Study Completion
May 1, 2020
Last Updated
August 29, 2019
Record last verified: 2019-08